The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Abstract East Asian patients have reduced anti-ischemic benefits and increased bleeding risk during antithrombotic therapies compared with Caucasian patients. As potent P2Y 12 receptor inhibitors (e.g., ticagrelor and prasugrel) and direct oral anticoagulants are commonly used in current daily pract...

Full description

Bibliographic Details

Published in:	Thrombosis and haemostasis Vol. 121; no. 4; pp. 422 - 432
Main Authors:	Kim, Hyun Kuk, Tantry, Udaya S., Smith, Sidney C., Jeong, Myung Ho, Park, Seung-Jung, Kim, Moo Hyun, Lim, Do-Sun, Shin, Eun-Seok, Park, Duk-Woo, Huo, Yong, Chen, Shao-Liang, Bo, Zheng, Goto, Shinya, Kimura, Takeshi, Yasuda, Satoshi, Chen, Wen-Jone, Chan, Mark, Aradi, Daniel, Geisler, Tobias, Gorog, Diana A., Sibbing, Dirk, Lip, Gregory Y. H., Angiolillo, Dominick J., Gurbel, Paul A., Jeong, Young-Hoon
Format:	Journal Article
Language:	English
Published:	Rüdigerstraße 14, 70469 Stuttgart, Germany Georg Thieme Verlag KG 01.04.2021
Subjects:	Review Article direct oral anticoagulants bleeding risk antiplatelet therapy race ischemic risk
ISSN:	0340-6245, 2567-689X, 2567-689X
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!